Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200 (Q56679480)
Jump to navigation
Jump to search
article by Bruce J. Giantonio et al published 20 April 2007 in Journal of Clinical Oncology
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200 |
article by Bruce J. Giantonio et al published 20 April 2007 in Journal of Clinical Oncology |
Statements
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200 (English)
0 references
20 April 2007
0 references
25
0 references
1539-1544
0 references
12
0 references